2023-503420-19-00
CTIS ↗
M602011072
Pediatric lower limb (LL) spasticity (SP) caused by cerebral palsy (CP)
pharma · Lower limb spasticity · Pediatric lower limb (LL) spasticity (SP) caused by cerebral palsy (CP)
Merz Therapeutics
Merz Pharmaceuticals GmbH
Merz Therapeutics trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
frankfurt am main, DE HQ
2020 Founded
1,312 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- frankfurt am main, DE
- Founded
- 2020
- Employees
- 1,312
- Programs
- 2
- Drugs
- 4
- Patents
- 0
Merz Therapeutics clinical trials
Registry index of 2 ClinicalTrials.gov studies linked to Merz Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Merz Therapeutics trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Merz Therapeutics.